The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

The bird flu, also known as avian influenza and H5N1, was implicated in the first human death from the infectious disease on ...

Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian ...

Outcomes and care related to stroke in London, United Kingdom, were notably different based on ethnicity, with major ...

Vitiligo, a skin condition causing depigmentation, may significantly increase the risk of serious cardiovascular events.

Mistrust in health care, concerns over safety, and ineffective communication surrounding vaccines were among the themes ...

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...

Americans who drank coffee in the morning had a lower overall mortality compared with those who drank coffee later in the day ...

Adding serial circulating tumor DNA (ctDNA) assays to standard of care imaging surveillance had limited clinical benefits in ...

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...

If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed.

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial ...